Miyagi, Japan

Yasuo Endo




Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations of Yasuo Endo in Vaccine Development

Introduction

Yasuo Endo is a notable inventor based in Miyagi, Japan, recognized for his contributions to the field of vaccine development. With a total of two patents to his name, Endo has made significant strides in creating effective therapeutic methods for infections.

Latest Patents

One of Yasuo Endo's latest patents is a vaccine for mycoplasma infection. This vaccine is disclosed to have a high therapeutic effect on infections while maintaining a high level of safety. The development of effective therapeutic methods involves the use of mimic particles that serve as a vaccine for infections. Additionally, bacterium-mimic particles, which include common bacteria, are provided. These mimic particles can be produced by creating liposome particles that contain a lipid antigen specific to pathogenic bacteria. The administration of these mimic particles enables the induction of potent immunological activity in living bodies. This innovation positions the mimic particles as an excellent vaccine for the prevention or treatment of infections.

Career Highlights

Yasuo Endo has worked with esteemed organizations such as the National Institute of Infectious Diseases and M Bio Technology Inc. His work in these institutions has contributed to advancements in infectious disease research and vaccine development.

Collaborations

Endo has collaborated with notable coworkers, including Kazuhiro Matsuda and Koji Ichiyama. Their collective efforts have furthered research in the field of immunology and vaccine technology.

Conclusion

Yasuo Endo's innovative work in vaccine development, particularly in creating effective solutions for mycoplasma infections, showcases his dedication to improving public health. His contributions are significant in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…